Intravitreal bevacizumab for choroidal neovascularization secondary to choroidal osteoma

5 600

Cited 14 times in

Authors: Won Kyung Song ; Hyoung Jun Koh ; Oh Woong Kwon ; Suk Ho Byeon ; Sung Chul Lee

MeSH: Angiogenesis Inhibitors/therapeutic use* ; Antibodies, Monoclonal/therapeutic use* ; Antibodies, Monoclonal, Humanized ; Bevacizumab ; Bone Neoplasms/complications* ; Choroid Neoplasms/complications* ; Choroidal Neovascularization/drug therapy* ; Choroidal Neovascularization/etiology ; Fluorescein Angiography ; Humans ; Injections ; Male ; Osteoma/complications* ; Vascular Endothelial Growth Factor A/antagonists & inhibitors ; Visual Acuity ; Vitreous Body ; Young Adult

Full Text: http://onlinelibrary.wiley.com/doi/10.1111/j.1600-0420.2007.01136.x/abstract

Appears in Collections:: 1. College of Medicine (의과대학) > Dept. of Ophthalmology (안과학교실) > 1. Journal Papers

Yonsei Authors: Koh, Hyoung Jun(고형준) https://orcid.org/0000-0002-5932-8516
Kwon, Oh Woong(권오웅)
Byeon, Suk Ho(변석호) https://orcid.org/0000-0001-8101-0830
Song, Won Kyung(송원경)
Lee, Sung Chul(이성철) https://orcid.org/0000-0001-9438-2385

Show full item record Find it @ YMLIB

YUHSpace: Intravitreal bevacizumab for choroidal neovascularization secondary to choroidal osteoma